Summit Therapeutics Inc.
SMMT
$25.26
$1.305.43%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -44.72% | -67.37% | -164.50% | -310.31% | 91.98% |
| Total Depreciation and Amortization | -7.41% | -26.67% | -37.50% | -56.52% | -70.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -13.25% | 55.11% | 685.83% | 1,704.68% | -98.28% |
| Change in Net Operating Assets | -247.36% | -108.00% | 114.48% | 122.96% | 2,393.99% |
| Cash from Operations | -102.99% | -150.13% | -103.38% | -12.74% | -129.49% |
| Capital Expenditure | -10,450.00% | -600.00% | -9.43% | -215.00% | 92.45% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 707.71% | 37.85% | -3,062.16% | -20,001,700.00% | 103.08% |
| Cash from Investing | 705.75% | 37.83% | -3,015.75% | -96,756.52% | 103.08% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1,482.89% | -87.08% | -- | -- | -99.54% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1,482.89% | -477.67% | 89,044.98% | 250,365.00% | -99.39% |
| Foreign Exchange rate Adjustments | 205.56% | -139.71% | 167.06% | -95.90% | -108.11% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,186.78% | -76.72% | 456.60% | -13.88% | 98.30% |